<?xml version="1.0" encoding="UTF-8"?>
<p id="para3890">Access to health insurance, affordable health care, and affordable essential medicines are also important issues in low-and-middle-income countries in the Asia-Pacific. SDG 3.8 aims to achieve universal health coverage, including protection from financial risk, access to good-quality, essential health-care services, and access to safe, effective, good-quality, and affordable essential medicines and vaccines for all by 2030. SDG 3.9b calls for the provision of access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS agreement and public health,
 <xref rid="bib436" ref-type="bibr">
  <sup>436</sup>
 </xref> which affirms the right of developing countries to fully use the provisions of the TRIPS agreement to provide access to medicines for all by 2030. To this end, health-financing systems should not only seek to raise sufficient funds for health provision but should also do so in a way that allows people to use services without risk of severe financial hardship or impoverishment.
 <xref rid="bib437" ref-type="bibr">
  <sup>437</sup>
 </xref> Three interrelated areas could bring health financing closer to universal health coverage: raising funds for health, reducing financial barriers to health-care access through prepayment and subsequent pooling of funds instead of direct out-of-pocket payments, and allocating or using funds in a way that promotes efficiency and equity. Public health systems and publicâ€“private partnerships need to be strengthened to face the challenges that an increasing burden of liver diseases could create, and measuring progress is an inherent part of any prevention and treatment strategy. We suggest a set of metrics to monitor the implementation of the various aspects of such a strategy (
 <xref rid="tbl6" ref-type="table">table 6</xref> ).
</p>
